GRO (GRO) Stock Price & Analysis
GRO (GRO) fell 2.27% to USD 2.15 as of July 25, 2026 at 04:19 UTC, according to Nexqual real-time market data.
GRO last closed at USD 2.2; the session ranged USD 2.13–2.26 on volume of 162,253 shares. Market capitalization is $131.78M, with a 52-week range of USD 1.45–3.99 (ASE). Source: Nexqual, July 25, 2026 at 04:19 UTC.
Key Statistics (as of July 25, 2026 at 04:19 UTC)
| Price | USD 2.15 |
|---|---|
| Change | ▼ 2.27% (down) |
| Previous Close | USD 2.2 |
| Open | USD 2.23 |
| Day Range | USD 2.13 – 2.26 |
| 52-Week Range | USD 1.45 – 3.99 |
| Volume | 162,253 shares |
| Market Cap | $131.78M |
| Exchange | ASE |
Technical Analysis (GRO)
Nexqual's technical model rates GRO "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 04:19 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 45.97 (neutral) |
| vs SMA50 | Below (USD 2.31) |
| MACD | -0.03 (negative) |
Analyst Ratings (GRO)
Wall Street analysts rate GRO "Strong Buy" based on 5 analysts, with a mean price target of USD 6.1 (range USD 3.5–12), per Nexqual as of July 25, 2026 at 04:19 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 5 |
| Mean Target | USD 6.1 |
| High Target | USD 12 |
| Low Target | USD 3.5 |
| Buy / Hold / Sell | 5 / 0 / 0 |
Earnings (GRO)
| EPS Estimate | USD -0.16 |
|---|---|
| Revenue Estimate | $0 |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-12-31 | USD -0.08 vs est -0.06 ▼ miss |
| 2025-09-30 | USD -0.29 vs est -0.07 ▼ miss |
| 2025-06-30 | USD -0.39 vs est -0.08 ▼ miss |
Source: Nexqual, July 25, 2026 at 04:19 UTC.
Financials & Fundamentals (GRO)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -35.46% |
| Debt / Equity | 0.35 |
| Current Ratio | 13.28 |
| Total Cash | $22.48M |
| Total Debt | $511,869 |
| Free Cash Flow | $-9.20M |
Source: Nexqual, July 25, 2026 at 04:19 UTC.
Financial Health Score (GRO)
Nexqual rates GRO's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 04:19 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Strong — $22M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$12M |
| Efficiency | Critical — ROE -35%, ROA -16.1% |
Ownership (GRO)
| Insider Ownership | +4.31% |
|---|---|
| Institutional Ownership | +33.29% |
| Shares Outstanding | 61.29M |
| Float | 44.39M |
| Short % of Float | +0.36% |
Source: Nexqual, July 25, 2026 at 04:19 UTC.
Leadership (GRO)
GRO is led by Matthew Simpson M.B.A., P.Eng. (age 50), CEO & Director, per Nexqual as of July 25, 2026 at 04:19 UTC.
| CEO & Director | Matthew Simpson M.B.A., P.Eng. (age 50) |
|---|---|
| Executive Chairman & Member of Advisory Board | Mayo M. Schmidt B.B.A. (age 67) |
| President | Sergio Leite |
| Vice President of Marketing | Marcos Pedrini |
Major Backers & Investors (GRO)
Notable institutional backers of GRO include Alyeska Investment Group, L.p., AWM Investment Company, Inc., Bastion Asset Management Inc., according to Nexqual as of July 25, 2026 at 04:19 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Alyeska Investment Group, L.p. | 5.98% |
| AWM Investment Company, Inc. | 4.11% |
| Bastion Asset Management Inc. | 1.64% |
| Hollencrest Capital Management | 0.64% |
| Renaissance Technologies | 0.64% |
| First Manhattan Co. LLC | 0.55% |
| Diversified Trust Company | 0.48% |
| Jane Street Group, LLC | 0.32% |
Source: Nexqual, July 25, 2026 at 04:19 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SEED | Origin Agritech Limited | USD 1.01 | ▲ 0% |
| ACTS | FIS Tactical Equity ETF | USD 26.35 | ▼ 2.25% |
| FEED | ENvue Medical, Inc. | USD 0.38 | ▲ 2.69% |
| LFT | Lument Finance Trust, Inc. | USD 0.8 | ▼ 4.76% |
| ENFY | Enlightify Inc. | USD 0.02 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:19 UTC. This page is informational and not investment advice.